Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $752.27M.
ENTERPRISE VALUE (EV)
$752.27M
Gyre Therapeutics, Inc.
Market Cap
$789.34M
Enterprise Value (EV)
$752.27M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Gyre Therapeutics, Inc. (GYRE) | $789.34M | $752.27M |
| Geron Corporation (GERN)vs › | $792.28M | $851.78M |
| AdaptHealth Corp. (AHCO)vs › | $796.62M | $2.82B |
| Apnimed, Inc. (APMD)vs › | $784.52M | N/A |
| InMode Ltd. (INMD)vs › | $804.16M | $412.43M |
| Sana Biotechnology, Inc. (SANA)vs › | $777.94M | $794.60M |
| Ardelyx, Inc. (ARDX)vs › | $805.31M | $964.31M |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $772.90M | $791.26M |
| Jade Biosciences, Inc. (JBIO)vs › | $812.67M | $706.05M |
| Attovia Therapeutics, Inc. (ATTO)vs › | $764.86M | $736.36M |
Market Cap
$789.34M
Total Debt
$0.00
Cash
$37.07M
Enterprise Value
$752.27M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
